Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Price:
46.8
CNY
-1.99%
Market Closed
Market Cap:
¥19.8B
Cash Flow Statement
Cash Flow Statement
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(374)
|
(471)
|
(411)
|
(509)
|
(491)
|
(524)
|
(579)
|
(580)
|
(617)
|
(601)
|
(589)
|
(603)
|
(652)
|
(665)
|
(635)
|
(621)
|
(674)
|
(690)
|
(691)
|
(677)
|
|
| Change in Working Capital |
(1 373)
|
(1 770)
|
(1 590)
|
(1 985)
|
(1 636)
|
(1 819)
|
(1 871)
|
(2 036)
|
(2 324)
|
(2 434)
|
(2 569)
|
(2 749)
|
(2 762)
|
(2 998)
|
(3 381)
|
(3 537)
|
(3 255)
|
(3 265)
|
(3 059)
|
(2 959)
|
|
| Cash from Operating Activities |
431
N/A
|
482
+12%
|
702
+46%
|
685
-2%
|
1 153
+68%
|
935
-19%
|
999
+7%
|
891
-11%
|
769
-14%
|
740
-4%
|
843
+14%
|
808
-4%
|
610
-24%
|
649
+6%
|
467
-28%
|
492
+6%
|
695
+41%
|
784
+13%
|
901
+15%
|
1 130
+26%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(90)
|
(111)
|
(132)
|
(227)
|
(271)
|
(333)
|
(362)
|
(358)
|
(353)
|
(306)
|
(294)
|
(254)
|
(274)
|
(308)
|
(347)
|
(375)
|
(378)
|
(677)
|
(613)
|
(562)
|
|
| Other Items |
3
|
4
|
(1 628)
|
(2 899)
|
(2 288)
|
(2 492)
|
(891)
|
291
|
335
|
(41)
|
(61)
|
273
|
(244)
|
(24)
|
(180)
|
(625)
|
(706)
|
(257)
|
(158)
|
147
|
|
| Cash from Investing Activities |
(86)
N/A
|
(108)
-25%
|
(1 760)
-1 536%
|
(3 125)
-78%
|
(2 558)
+18%
|
(2 826)
-10%
|
(1 253)
+56%
|
(67)
+95%
|
(18)
+73%
|
(347)
-1 779%
|
(355)
-2%
|
19
N/A
|
(518)
N/A
|
(332)
+36%
|
(527)
-59%
|
(1 001)
-90%
|
(1 084)
-8%
|
(934)
+14%
|
(771)
+18%
|
(414)
+46%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(15)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
81
|
43
|
565
|
540
|
527
|
412
|
102
|
93
|
|
| Cash Paid for Dividends |
0
|
0
|
(191)
|
(191)
|
(191)
|
(192)
|
(231)
|
(254)
|
(254)
|
0
|
(362)
|
(339)
|
(339)
|
(340)
|
(255)
|
(259)
|
(263)
|
(265)
|
(269)
|
(268)
|
|
| Other |
(106)
|
2 769
|
2 869
|
2 845
|
2 855
|
(34)
|
(41)
|
(40)
|
(66)
|
(73)
|
(83)
|
(71)
|
(201)
|
(296)
|
(326)
|
(341)
|
(212)
|
(120)
|
(89)
|
(85)
|
|
| Cash from Financing Activities |
(121)
N/A
|
2 754
N/A
|
2 635
-4%
|
2 612
-1%
|
2 664
+2%
|
(225)
N/A
|
(272)
-21%
|
(294)
-8%
|
(320)
-9%
|
(327)
-2%
|
(445)
-36%
|
(410)
+8%
|
(458)
-12%
|
(594)
-29%
|
(16)
+97%
|
(60)
-275%
|
52
N/A
|
27
-48%
|
(257)
N/A
|
(260)
-1%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
1
|
(1)
|
(0)
|
7
|
(5)
|
|
| Net Change in Cash |
224
N/A
|
3 128
+1 298%
|
1 578
-50%
|
172
-89%
|
1 258
+633%
|
(2 116)
N/A
|
(526)
+75%
|
529
N/A
|
431
-19%
|
66
-85%
|
44
-33%
|
417
+840%
|
(367)
N/A
|
(277)
+24%
|
(78)
+72%
|
(568)
-624%
|
(338)
+40%
|
(123)
+63%
|
(119)
+3%
|
451
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
342
N/A
|
370
+8%
|
570
+54%
|
458
-20%
|
882
+92%
|
601
-32%
|
637
+6%
|
532
-16%
|
416
-22%
|
434
+4%
|
550
+27%
|
554
+1%
|
336
-39%
|
342
+2%
|
120
-65%
|
117
-2%
|
316
+171%
|
107
-66%
|
288
+169%
|
569
+98%
|
|
Switch to:
Switch to:
See Also
Discover More
